Literature DB >> 32503835

Addendum. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020;43(Suppl. 1):S98-S110.

.   

Abstract

Entities:  

Year:  2020        PMID： 32503835     DOI： 10.2337/dc20-ad08a

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  8 in total

1.  The Role of Antihyperglycemic Drugs and Diet on Erectile Function: Results from a Perspective Study on a Population with Prediabetes and Diabetes.

Authors:  Giuseppe Defeudis; Alfonso Maria Di Tommaso; Claudia Di Rosa; Danilo Cimadomo; Yeganeh Manon Khazrai; Antongiulio Faggiano; Raffaele Ivan Cincione; Nicola Napoli; Rossella Mazzilli
Journal:  J Clin Med       Date:  2022-06-13       Impact factor: 4.964

Review 2.  Diabetes in People with HIV.

Authors:  Sudipa Sarkar; Todd T Brown
Journal:  Curr Diab Rep       Date:  2021-03-17       Impact factor: 4.810

3.  SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort.

Authors:  Fateen Ata; Zohaib Yousaf; Adeel Ahmad Khan; Almurtada Razok; Jaweria Akram; Elrazi Awadelkarim Hamid Ali; Ahmed Abdalhadi; Diaeldin Abdelgalil Ibrahim; Dabia Hamad S H Al Mohanadi; Mohammed I Danjuma
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

4.  Machine Learning Approach to Decision Making for Insulin Initiation in Japanese Patients With Type 2 Diabetes (JDDM 58): Model Development and Validation Study.

Authors:  Kazuya Fujihara; Yasuhiro Matsubayashi; Mayuko Harada Yamada; Masahiko Yamamoto; Toshihiro Iizuka; Kosuke Miyamura; Yoshinori Hasegawa; Hiroshi Maegawa; Satoru Kodama; Tatsuya Yamazaki; Hirohito Sone
Journal:  JMIR Med Inform       Date:  2021-01-27

5.  Inhibitory effect of PPARγ on NLRP3 inflammasome activation.

Authors:  Ching-Chun Yang; Chih-Hsing Wu; Ta-Chun Lin; Yi-Ning Cheng; Chin-Sung Chang; Kuo-Ting Lee; Pei-Jane Tsai; Yau-Sheng Tsai
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 6.  Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy.

Authors:  Mouhamed Nashawi; Mahmoud S Ahmed; Toka Amin; Mujahed Abualfoul; Robert Chilton
Journal:  World J Cardiol       Date:  2021-12-26

7.  Treatment Dynamics in People Who Initiate Metformin or Sulfonylureas for Type 2 Diabetes: A National Cohort Study.

Authors:  Stephen Wood; Dianna J Magliano; J Simon Bell; Jonathan E Shaw; Jenni Ilomäki
Journal:  Front Pharmacol       Date:  2021-12-14       Impact factor: 5.810

Review 8.  Insulin Resistance Is Cheerfully Hitched with Hypertension.

Authors:  Susmita Sinha; Mainul Haque
Journal:  Life (Basel)       Date:  2022-04-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.